Sichuan Kelun Pharmaceutical Co Ltd.
https://en.kelun.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sichuan Kelun Pharmaceutical Co Ltd.
Anti-TROP2 ADCs Lung Cancer Futures Likely Lie In Earlier-Stage Disease
The discussant at ASCO’s NSCLC session said the field would need to “manage expectations” as the drugs do not appear to beat chemotherapy in all-comers.
Bladder Cancer Failure Is Another Setback For Gilead’s Trodelvy
A missed survival endpoint in the TROPiCS-04 confirmatory trial could spell end to Trodelvy's bladder cancer use, but Gilead is more hopeful of lung cancer success.
Diversification Gains Momentum As Companies Look To Derisk China
Quietly but unambiguously, pharma firms are accelerating their diversification away from China and are now looking to other emerging markets for growth, a strategy that reflects increasing pressures from China's volume-based procurement scheme but also US-China tensions and other geopolitical risks.
China Biotech Interview: BeiGene Co-Founder Wang Eyes Next Big Things
BeiGene co-founder and chair of the major global biotech's Scientific Advisory Board, Dr. Xiaodong Wang, sits down with Scrip in an exclusive audio interview to shed light on the rapid rise of China's biotech innovation, the country's role in BeiGene's global strategy and the next big things to watch.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Nutraceuticals
- Vaccines
-
Biotechnology
- Gene Therapy, Cell Therapy
-
Large Molecule
- Antibodies
-
Drug Discovery Technologies
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
- Other Names / Subsidiaries
-
- Guangxi Kelun Pharmaceutical Co Ltd
- Hunan Kelun Pharmaceutical Co Ltd
- Hubei Kelun Pharmaceutical Co Ltd
- Kelun Pharmaceutical Group
- KLUS Pharma Inc
- Shandong Kelun Pharmaceutical Co Ltd
- Sichuan Kelun Pharmaceutical Research Co Ltd
- Suzhou Kelun Pharmaceutical Research Co Ltd
- Sichuan Xindi Pharmaceutical Chemicals Co Ltd
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice